Sarepta Therapeutics Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Millions MXN. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jan '26 Jan 28, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	29,744	40,598	242,010	152,503	221,879	160,750
Market Cap Growth	-86.17%	-83.23%	58.69%	-31.27%	38.03%	-39.95%
Enterprise Value	31,485	47,967	246,521	146,686	212,745	152,104
Last Close Price	361.00	395.00	-	-	-	-
PE Ratio	-	-	49.37	-	-	-
PS Ratio	0.75	1.03	6.11	7.26	12.19	11.17
PB Ratio	1.45	1.98	7.60	10.50	29.55	8.45
P/TBV Ratio	1.45	1.98	7.74	10.87	30.14	8.58
EV/Sales Ratio	0.82	1.21	6.22	6.98	11.69	10.57
EV/EBITDA Ratio	-	-	46.25	-	-	-
EV/EBIT Ratio	-	-	54.25	-	-	-
Debt / Equity Ratio	0.91	0.91	0.88	1.61	4.20	1.23
Debt / EBITDA Ratio	-	-	3.74	-	-	-
Net Debt / Equity Ratio	0.09	0.09	-0.01	-0.35	-0.97	-1.05
Net Debt / EBITDA Ratio	-0.16	-0.16	-0.05	1.33	0.75	2.41
Net Debt / FCF Ratio	-	-	0.04	0.52	1.04	2.03
Asset Turnover	0.60	0.60	0.53	0.39	0.30	0.23
Inventory Turnover	2.84	2.84	2.10	3.90	5.21	4.12
Quick Ratio	1.22	1.22	2.74	3.23	3.63	5.05
Current Ratio	2.32	2.32	4.20	3.95	4.13	5.75
Return on Equity (ROE)	-53.47%	-53.47%	19.71%	-86.15%	-107.16%	-49.57%
Return on Assets (ROA)	-11.24%	-11.24%	3.77%	-5.24%	-10.68%	-9.04%
Return on Invested Capital (ROIC)	-44.29%	-47.73%	18.93%	-93.16%	-	-
Return on Capital Employed (ROCE)	-29.20%	-29.20%	6.70%	-10.30%	-21.40%	-16.50%
Earnings Yield	-43.18%	-31.64%	2.02%	-5.94%	-6.19%	-5.34%
FCF Yield	-	-	-2.95%	-6.40%	-3.13%	-6.14%
Buyback Yield / Dilution	7.19%	7.19%	-16.75%	-5.53%	-7.75%	-4.24%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.